E-ISSN 2148-5607
RELATED ARTICLES
Editorial
HDV infection in liver cirrhosis
(Turk J Gastroenterol 1996; 7: 1-5)
The effect of somatostatin analogue (SMS 201-995) on renal function in patients with decompansated cirrhosis and helathy volunteers
(Turk J Gastroenterol 1996; 7: 22-26)
Serum digoxin-like immunoreactive substances in chronic liver disease
(Turk J Gastroenterol 1997; 8: 283-285)
histological outcome after interferon therapy in chronic viral hepatitis
(Turk J Gastroenterol 1997; 8: 291-294)
Successful treatment of primary Sjögren’s syndrome complicated with primary biliary cirrhosis and lung involvement
(Turk J Gastroenterol 2010; 21: 60-62)
DOI: 10.4318/tjg.2010.0051
Anadoluda anne ve bebeklerinde Helikobakter pilori enfeksiyonu
(Turk J Gastroenterol 2010; 21: 113-118)
DOI: 10.4318/tjg.2010.0067
Serum selenium concentrations in cirrhotic children
(Turk J Gastroenterol 2010; 21: 153-155)
DOI: 10.4318/tjg.2010.0074
Utilization of impedance cardiography in noninvasive assessment of hemodynamic status in cirrhotic patients
(Turk J Gastroenterol 2010; 21: 280-286)
DOI: 10.4318/tjg.2010.0101
Is there any relationship between Behçet's disease and hepatit C virus?
(Turk J Gastroenterol 1998; 9: 10-13)
Central and nonsplanchnic hemodynamic changes in liver cirrhosis
(Turk J Gastroenterol 1998; 9: 14-20)
Delta infection among children with cronic viral hepatitis
(Turk J Gastroenterol 1998; 9: 21-23)
Effects of Giardia lamblia infestation on the clinical sourse of cronic hepatitis B
(Turk J Gastroenterol 1998; 9: 24-27)
Acute rubeola hepatitis
(Turk J Gastroenterol 1998; 9: 66-69)
Acral erythema induced bu interferon alpha in a child
(Turk J Gastroenterol 1998; 9: 70-72)
Hepatitis C infection in non-Hodgkin's lymphoma
(Turk J Gastroenterol 1998; 9: 73-75)
Hepatitis C virus and deep abdominal lymphadenopathy
(Turk J Gastroenterol 1998; 9: 91-94)
Osteoporosis and bone metabolism in cirrhotic patients
(Turk J Gastroenterol 1998; 9: 95-100)
Effect of anti-HCV positifity on response to hepatitis B virus vaccine in haemodialysis patients
(Turk J Gastroenterol 1998; 9: 105-107)
Etiologies of chronic hepatitis
(Turk J Gastroenterol 1998; 9: 113-115)
Apoptosis in selected liver diseases
(Turk J Gastroenterol 2009; 20: 171-179)
DOI: 10.4318/tjg.2009.0003
The quality of life in hemodialysis patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2009; 20: 243-246)
DOI: 10.4318/tjg.2009.0020
Prevelance and genotyping of hepatitis C virus RNA in Turkish patinets with non-A, non-B liver disease
(Turk J Gastroenterol 1998; 9: 208-212)
The prevalence of hepatocellular carcinoma in patients with liver cirrhosis in Southeastern Turkey
(Turk J Gastroenterol 1998; 9: 217-220)
Lamivudine resistance in untreated chronic hepatitis B patients in Turkey
(Turk J Gastroenterol 2008; 19: 99-103)
Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey
(Turk J Gastroenterol 2008; 19: 104-108)
Alterations in serum levels of the natural anticoagulants in chronic liver disease and their relations to portal thrombosis
(Turk J Gastroenterol 1998; 9: 313-316)
Is there any correlation between anti-HBc IgM index and HBV DNA level in patients with chroin hepatitis B?
(Turk J Gastroenterol 1998; 9: 317-319)
The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC
(Turk J Gastroenterol 2008; 19: 250-253)
Transient sinus bradycardia in a child during the course of acute hepatitis A
(Turk J Gastroenterol 2007; 18: 195-197)
Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis
(Turk J Gastroenterol 2007; 18: 245-249)
Pegylated interferon treatment of acute pericarditis associated with acute hepatitis C
(Turk J Gastroenterol 2007; 18: 268-271)
The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies
(Turk J Gastroenterol 2006; 17: 25-34)
Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: One year follow-up after 48 weeks of treatment
(Turk J Gastroenterol 2006; 17: 35-39)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 94-98)
Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure
(Turk J Gastroenterol 2006; 17: 148-150)
Change in plasma concentrations of lipid peroxidation products in patients with acute viral hepatitis
(Turk J Gastroenterol 1999; 10: 4-6)
The value of ultrasonography in the diagnosis of early cirrhosis*
(Turk J Gastroenterol 1999; 10: 7-10)
Gallbladder wall thickening as a sign of esophageal varices in chronic liver disease*
(Turk J Gastroenterol 1999; 10: 11-14)
An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection
(Turk J Gastroenterol 2006; 17: 203-205)
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Hepatitis B and C virus in West-Central Turkey: Seroprevalence in healthy individuals admitted to a university hospital for routine health checks
(Turk J Gastroenterol 2006; 17: 267-272)
P21 expression and its relation to disease activity and hepatocyte proliferation in chronic hepatitis B virus infection
(Turk J Gastroenterol 2005; 16: 12-16)
Spontaneous bacterial peritonitis due to Brucella Melitensis in a cirrhotic patient
(Turk J Gastroenterol 2005; 16: 38-40)
The coexistence of hepatitis A and infectious mononucleosis
(Turk J Gastroenterol 2005; 16: 102-104)
A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis
(Turk J Gastroenterol 2005; 16: 119-123)
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment
(Turk J Gastroenterol 2005; 16: 124-128)
Importance of anticoagulant proteins in chronic liver diseases
(Turk J Gastroenterol 2005; 16: 129-133)
Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey
(Turk J Gastroenterol 2005; 16: 183-187)
Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children
(Turk J Gastroenterol 2005; 16: 188-193)
Coeliac disease, autoimmune thyroid disease and primary biliary cirrhosis: Case report
(Turk J Gastroenterol 1999; 10: 167-170)
The diagnostic role of ultrasonography in liver steatosis
(Turk J Gastroenterol 1999; 10: 96-100)
Serum nitric oxide in liver cirrhosis and its relation to blood pressure
(Turk J Gastroenterol 1999; 10: 315-318)
Seroepidemiology of delta hepatitis in Turkey
(Turk J Gastroenterol 1999; 10: 316-327)
Portal colopathy findings in patients with liver cirrhosis
(Turk J Gastroenterol 1999; 10: 328-333)
Per-oral scintigraphic evaluation of upper portosystemic shunts in portal hypertension
(Turk J Gastroenterol 1999; 10: 340-344)
The effect of somatostatin infusion on plasma glucagon levels in cirrhotic patients with ascites
(Turk J Gastroenterol 2000; 11: 113-116)
Daily use of consensus interferon: One-year treatment results for chronic hepatitis C patients relapsing ornon-responding to previous interferon
(Turk J Gastroenterol 2000; 11: 191-195)
L-Carnitine therapy in non-alcoholic steatohepatitis
(Turk J Gastroenterol 2000; 11: 196-201)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: A prospective epidemiologic study
(Turk J Gastroenterol 2004; 15: 11-13)
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels
(Turk J Gastroenterol 2004; 15: 14-20)
Esophageal variceal ligation for acute variceal bleeding: Results of three years' follow-up
(Turk J Gastroenterol 2004; 15: 27-33)
Nitric oxide and renal functions in liver cirrhosis
(Turk J Gastroenterol 2004; 15: 73-76)
Cardiovascular problems in cirrhotic patients
(Turk J Gastroenterol 2004; 15: 126-132)
Lichen planus and HCV infection in Turkish patients
(Turk J Gastroenterol 2004; 15: 133-136)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Active factor VII levels in patients with cirrhosis
(Turk J Gastroenterol 2001; 12: 100-103)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
Hepatopulmoner sendrom
(Turk J Gastroenterol 2001; 12: 179-184)
Cerebral magnetic resonance imaging findings in stable cirrhotic patients without clinical signs of hepatic encephalopathy
(Turk J Gastroenterol 2001; 12: 196-202)
Effects of Helicobacter pylori and liver cirrhosis on gastric mucosal hexosamine concentrations
(Turk J Gastroenterol 2001; 12: 206-210)
Ursodeoxycholic acid can be used as a steroid-tapering drug in the treatment of autoimmune hepatitis
(Turk J Gastroenterol 2001; 12: 249-252)
The increased incidence of vagal neuropathy in cirrhosis
(Turk J Gastroenterol 2001; 12: 258-262)
Hepatitis B seroprevalance and risk factors in urban areas of Malatya
(Turk J Gastroenterol 2002; 13: 1-5)
The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection
(Turk J Gastroenterol 2002; 13: 6-10)
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis
(Turk J Gastroenterol 2002; 13: 60-62)
Obesity and related parameters of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2002; 13: 71-77)
Prolonged jaundice, azotomia and leucopenia in a patient with acute type B virus hepatitis
(Turk J Gastroenterol 1996; 7: 86-89)
A case of terbinafine associated hepatic injury
(Turk J Gastroenterol 1996; 7: 90-92)
Chronic hepatitis C with mixed cryoglubulinemia: A cade report
(Turk J Gastroenterol 1996; 7: 254-256)
Glucose intolerance in chronic C hepatitis patients in turkey
(Turk J Gastroenterol 1996; 7: 289-292)
The level of antithrombin III in cases with primer hepatocellular cancer
(Turk J Gastroenterol 1996; 7: 295-297)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Spontaneous bacterial peritonitis due to Brucella infection
(Turk J Gastroenterol 2003; 14: 145-147)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
The use of tissue polypeptide specific antigen as a marker in liver diseases
(Turk J Gastroenterol 2003; 14: 177-180)
Type 1 gastric carcinoid tumor: another extrahepatic manifestation of hepatitis C virus infection?
(Turk J Gastroenterol 2003; 14: 194-196)
A case of autoimmune hepatitis and autoimmune hemolytic anemia following hepatitis A infection
(Turk J Gastroenterol 2003; 14: 204-207)
Nimesulide-induced fulminant hepatitis
(Turk J Gastroenterol 2003; 14: 208-210)
Two findings of portal hypertension: Evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis
(Turk J Gastroenterol 2003; 14: 219-222)
The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 228-233)
A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders
(Turk J Gastroenterol 2003; 14: 234-238)
Acute oligo-anuric renal failure during the course of non-fulminant hepatitis A in a patient with anorexia nervosa
(Turk J Gastroenterol 2002; 13: 164-167)
Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 12-17)
Evaluation of the outcome of interferon therapy in chronic hepatitis B infection
(Turk J Gastroenterol 1999; 10: -)
Autoantibodies in chronic viral hepatitis and autoimmune hepatitis
(Turk J Gastroenterol 1997; 8: 381-384)
Importance of second and third generation ELISA test in detection of HVC antibody
(Turk J Gastroenterol 1997; 8: 144-147)
Response to hepatitis B vaccine in patients with non-hepatitis B chronic liver disease
(Turk J Gastroenterol 1997; 8: 148-151)
The early diagnosis of hepatopulmonary syndrome by 99mTc-MAA scintigraphy in chronic liver disease
(Turk J Gastroenterol 1997; 8: 385-391)
Gallbladder wall thickening and emptying function in liver cirrhosis
(Turk J Gastroenterol 1997; 8: 397-401)
Prevalence of osteoporosis in liver cirrhosis
(Turk J Gastroenterol 1997; 8: 156-159)
Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study
(Turk J Gastroenterol 2009; 20: 27-30)
Relationship of increased serum brain natriuretic peptide levels with hepatic failure, portal hypertension and treatment in patients with cirrhosis
(Turk J Gastroenterol 2010; 21: 381-386)
DOI: 10.4318/tjg.2010.0124
Transmission routes of chronic hepatitis C and their relation to HCV genotypes
(Turk J Gastroenterol 2010; 21: 396-400)
DOI: 10.4318/tjg.2010.0126
Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha
(Turk J Gastroenterol 2010; 21: 401-410)
DOI: 10.4318/tjg.2010.0127
Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome
(Turk J Gastroenterol 2010; 21: 411-415)
DOI: 10.4318/tjg.2010.0128
Fulminant hepatic failure related to Wilson’s disease
(Turk J Gastroenterol 1999; 10: 227-231)
Detection of HEV antibody seroprevalance in HAV antibody positive subjects
(Turk J Gastroenterol 1999; 10: 232-235)
Relationship between serum levels of interleukin-10, interleukin-2 and soluble intercellular adhesion molecule-I and liver injury in chronic hepatitis B virus infection
(Turk J Gastroenterol 1999; 10: 243-248)
HCV genotypes in HCV related chronic hepatitis in Southeast Anatolia
(Turk J Gastroenterol 1999; 10: 249-252)
Giant cell hepatitis and autoimmune hemolytic anemia after chickenpox
(Turk J Gastroenterol 2010; 21: 448-451)
DOI: 10.4318/tjg.2010.0135
Liver cell adenoma in a male patient with cirrhosis
(Turk J Gastroenterol 1997; 8: 247-250)
Review
Apoptosis and fibrosis in non-alcoholic fatty liver disease
(Turk J Gastroenterol 2005; 16: 1-6)
Peri and postoperative pulmonary complications among cirrhotic individuals
(Turk J Gastroenterol 2004; 15: 207-212)
Importance of malnutrition in patients with cirrhosis
(Turk J Gastroenterol 2015; 26: 291-296)
DOI: 10.5152/tjg.2015.0224
Show Me Echo – Hepatitis C: A telemedicine mentoring program for patients with hepatitis C in underserved and rural areas in Missouri as a model in developing countries
(Turk J Gastroenterol 2015; 26: 447-449)
DOI: 10.5152/tjg.2015.159000
Emerging therapeutics and relevant targets for chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 210-215)
DOI: 10.5152/tjg.2016.15521
Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management
(Turk J Gastroenterol 2014; 25: 127-132)
DOI: 10.5152/tjg.2014.7675
New modalities in the treatment of HCV in pre and post - transplantation setting
(Turk J Gastroenterol 2015; 26: 204-213)
DOI: 10.5152/tjg.2015.0204
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report
(Turk J Gastroenterol 2018; 29: 259-269)
DOI: 10.5152/tjg.2018.18263
Non-invasive diagnosis of esophageal varices after Baveno VI
(Turk J Gastroenterol 2017; 28: 159-165)
DOI: 10.5152/tjg.2017.16744
Case Report
A case of entecavir-associated bullous fixed drug eruption and a review of literature
(Turk J Gastroenterol 2019; 30: 299-302)
DOI: 10.5152/tjg.2018.17887
A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
(Turk J Gastroenterol 2014; 25: 206-209)
DOI: 10.5152/tjg.2014.3605
Recurrent bleeding of parastomal varices: Case report
(Turk J Gastroenterol 2011; 22: 329-332)
DOI: 10.4318/tjg.2011.0221
Severe aplastic anemia following liver transplantation in a patient with non-A-E fulminant hepatitis
(Turk J Gastroenterol 2011; 22: 337-340)
DOI: 10.4318/tjg.2011.0222
Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A
(Turk J Gastroenterol 2005; 16: 217-219)
A case of herpes simplex hepatitis with hepatic nodules in an immunocompetent patient
(Turk J Gastroenterol 2007; 18: 115-118)
Acute hepatitis induced by Epstein- Barr virus infection: A case report
(Turk J Gastroenterol 2007; 18: 119-121)
Spontaneous splenic infarction in an elderly cirrhotic patient with multiple comorbidities
(Turk J Gastroenterol 2012; 23: 596-598)
DOI: 10.4318/tjg.2012.0429
Cyclosporine rescue therapy in autoimmune liver cirrhosis: A case report
(Turk J Gastroenterol 2012; 23: 599-603)
DOI: 10.4318/tjg.2012.0438
Alström syndrome with liver cirrhosis: First case from Turkey
(Turk J Gastroenterol 2013; 24: 546-548)
DOI: 10.4318/tjg.2013.0587
Icterohaemorrhagic leptospirosis in patients with history of alcohol abuse – report of two cases
(Turk J Gastroenterol 2013; 24: 549-555)
DOI: 10.4318/tjg.2013.0588
A case of gynecomastia due to entecavir
(Turk J Gastroenterol 2010; 21: 313-316)
DOI: 10.4318/tjg.2010.0108
Fascioliasis: 3 cases with three different clinical presentations
(Turk J Gastroenterol 2012; 23: 267-271)
DOI: 10.4318/tjg.2012.0388
Gastric cancer after cadaveric liver transplantation in a patient with autoimmune hepatitis: A case report and review of the literature
(Turk J Gastroenterol 2011; 22: 73-76)
DOI: 10.4318/tjg.2011.0160
Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension
(Turk J Gastroenterol 2014; 25: 429-432)
DOI: 10.5152/tjg.2014.7688
Original Article
Acute liver failure in Turkey: A systematic review
(Turk J Gastroenterol 2014; 25: 35-40)
DOI: 10.5152/tjg.2014.4231
Drug- and herb-induced liver injury: A case series from a single center
(Turk J Gastroenterol 2014; 25: 41-45)
DOI: 10.5152/tjg.2014.4486
The long-term mortality of spontaneous bacterial peritonitis in cirrhotic patients: A 3-year nationwide cohort study
(Turk J Gastroenterol 2015; 26: 159-162)
DOI: 10.5152/tjg.2015.4829
Epidemiological shift of hepatitis A in central Adana, Turkey
(Turk J Gastroenterol 2014; 25: 6-8)
DOI: 10.5152/tjg.2014.4163
Fatty liver disease might increase the risk of abdominal operation in patients with fatty liver and the prevalence of cancer in first-degree relatives
(Turk J Gastroenterol 2014; 25: 138-141)
DOI: 10.5152/tjg.2014.7674
Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection
(Turk J Gastroenterol 2014; 25: 142-146)
DOI: 10.5152/tjg.2014.5711
A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis
(Turk J Gastroenterol 2014; 25: 167-175)
DOI: 10.5152/tjg.2014.5121
Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description
(Turk J Gastroenterol 2011; 22: 606-611)
DOI: 10.4318/tjg.2011.0323
Ornidazole-induced autoimmune hepatitis
(Turk J Gastroenterol 2011; 22: 494-499)
DOI: 10.4318/tjg.2011.0245
The impact of hepatitis C virus infection on long-term outcome in renal transplant patients
(Turk J Gastroenterol 2011; 22: 165-170)
DOI: 10.4318/tjg.2011.0236
AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2011; 22: 279-285)
DOI: 10.4318/tjg.2011.0213
Characteristics of patients dying from acute viral hepatitis in Serbia
(Turk J Gastroenterol 2011; 22: 152-157)
DOI: 10.4318/tjg.2011.0184
Prevelance of hepatitis D co-enfection in children with hepatitis B infection: Cross-sectional analyses from Western Turkey
(Turk J Gastroenterol 2013; 24: 345-348)
DOI: 10.4318/tjg.2013.0681
Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey
(Turk J Gastroenterol 2013; 24: 349-355)
DOI: 10.4318/tjg.2013.0518
Clinical features of elderly Chinese patients with autoimmune hepatitis
(Turk J Gastroenterol 2013; 24: 489-494)
DOI: 10.4318/tjg.2013.0592
Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients
(Turk J Gastroenterol 2012; 23: 538-545)
DOI: 10.4318/tjg.2012.0358
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis
(Turk J Gastroenterol 2012; 23: 560-568)
DOI: 10.4318/tjg.2012.0538
Alpha-1 antitrypsin deficiency in patients with chronic hepatitis
(Turk J Gastroenterol 2012; 23: 569-573)
DOI: 10.4318/tjg.2012.0379
Risk factors for higher anti-HCV positivity in a border city in southern Turkey with unique population characteristics
(Turk J Gastroenterol 2012; 23: 574-579)
DOI: 10.4318/tjg.2012.0554
Molecular characterization of hepatitis A virus isolated from acute infections in Turkey
(Turk J Gastroenterol 2012; 23: 714-719)
DOI: 10.4318/tjg.2012.0450
Investigation into bacteremia and spontaneous bacterial peritonitis in patients with liver cirrhosis in Japan
(Turk J Gastroenterol 2012; 23: 122-126)
DOI: 10.4318/tjg.2012.0321
Serum complement C4 in chronic hepatitis C: Correlation with histopathologic findings and disease activity
(Turk J Gastroenterol 2012; 23: 33-37)
DOI: 10.4318/tjg.2012.0310
AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 353-358)
DOI: 10.4318/tjg.2012.0348
Noninvasive assessment of portal hypertension in patients with alcoholic cirrhosis
(Turk J Gastroenterol 2012; 23: 239-246)
DOI: 10.4318/tjg.2012.0463
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 247-252)
DOI: 10.4318/tjg.2012.0380
Additional BCAA-enriched nutrient mixture improves the nutritional condition in cirrhotic patients with hypoalbuminemia despite treatment with regular BCAA granules: A pilot study
(Turk J Gastroenterol 2015; 26: 328-335)
DOI: 10.5152/tjg.2015.0202
The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters
(Turk J Gastroenterol 2015; 26: 408-416)
DOI: 10.5152/tjg.2015.6336
The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization
(Turk J Gastroenterol 2015; 26: 423-428)
DOI: 10.5152/tjg.2015.0063
Gallstones in liver transplant recipients: A single-center study in China
(Turk J Gastroenterol 2015; 26: 429-434)
DOI: 10.5152/tjg.2014.6344
Ten-year analysis of hepatitis-related papers in the Middle East: a web of science-based scientometric study
(Turk J Gastroenterol 2017; 28: 20-25)
DOI: 10.5152/tjg.2016.0572
Mean arterial pressure drop is an independent risk factor of death in patients with HBV-related cirrhosis ascites
(Turk J Gastroenterol 2017; 28: 26-30)
DOI: 10.5152/tjg.2016.0412
Responsiveness of children with celiac disease to different hepatitis B vaccination protocols
(Turk J Gastroenterol 2011; 22: 27-31)
DOI: 10.4318/tjg.2011.0152
Glutathione and glutathione S-transferase levels in patients with liver metastases of colorectal cancer and other hepatic disorders
(Turk J Gastroenterol 2016; 27: 336-341)
DOI: 10.5152/tjg.2016.15457
Insight into the natural history of primary biliary cirrhosis: A systemic review of data from placebo-controlled clinical trials
(Turk J Gastroenterol 2016; 27: 342-348)
DOI: 10.5152/tjg.2016.15535
Role of Th1/Th2 cells and related cytokines in autoimmune hepatitis
(Turk J Gastroenterol 2017; 28: 110-114)
DOI: 10.5152/tjg.2017.17501
Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir
(Turk J Gastroenterol 2016; 27: 42-46)
DOI: 10.5152/tjg.2015.150348
Relations between human leukocyte antigens and autoimmune hepatitis in Turkish children
(Turk J Gastroenterol 2011; 22: 42-46)
DOI: 10.4318/tjg.2011.0155
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B
(Turk J Gastroenterol 2015; 26: 36-41)
DOI: 10.5152/tjg.2015.4636
Hepatic granulomas in Turkey: A 6-year clinicopathological study of 35 cases
(Turk J Gastroenterol 2014; 25: 524-528)
DOI: 10.5152/tjg.2014.5417
Cirrhotic Ascites management via procalcitonin level and a new approach B-mode gray-scale histogram
(Turk J Gastroenterol 2016; 27: 47-54)
DOI: 10.5152/tjg.2015.150345
Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis?
(Turk J Gastroenterol 2016; 27: 349-353)
DOI: 10.5152/tjg.2016.160042
Effect of coronary-caval shunt combined with partial pericardial devascularisation on oesophageal and gastric variceal bleeding caused by portal hypertension
(Turk J Gastroenterol 2016; 27: 354-360)
DOI: 10.5152/tjg.2016.16086
Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?
(Turk J Gastroenterol 2016; 27: 55-61)
DOI: 10.5152/tjg.2015.150280
The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2016; 27: 156-164)
DOI: 10.5152/tjg.2015.150449
Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis
(Turk J Gastroenterol 2015; 26: 244-250)
DOI: 10.5152/tjg.2015.0074
Effect of SIRS and sepsis on mortality in alcoholic hepatitis: A systematic review and meta-analysis
(Turk J Gastroenterol 2016; 27: 458-463)
DOI: 10.5152/tjg.2016.16188
Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C
(Turk J Gastroenterol 2014; 25: 539-545)
DOI: 10.5152/tjg.2014.6170
Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency
(Turk J Gastroenterol 2014; 25: 405-410)
DOI: 10.5152/tjg.2014.7083
The relation between liver histopathology and GGT levels in viral hepatitis: More important in hepatitis B
(Turk J Gastroenterol 2014; 25: 411-415)
DOI: 10.5152/tjg.2014.3693
The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey
(Turk J Gastroenterol 2014; 25: 546-552)
DOI: 10.5152/tjg.2014.7829
Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy
(Turk J Gastroenterol 2014; 25: 304-308)
DOI: 10.5152/tjg.2014.6718
Variceal bleeding in cirrhotic patients: What is the best prognostic score?
(Turk J Gastroenterol 2016; 27: 464-469)
DOI: 10.5152/tjg.2016.16250
Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy
(Turk J Gastroenterol 2016; 27: 367-374)
DOI: 10.5152/tjg.2016.16100
The importance of salivary cortisol in the diagnosis of adrenal insufficiency in cirrhosis
(Turk J Gastroenterol 2016; 27: 268-272)
DOI: 10.5152/tjg.2016.15544
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
(Turk J Gastroenterol 2016; 27: 165-172)
DOI: 10.5152/tjg.2016.150300
KDIGO (Kidney Disease: Improving Global Outcomes) criteria as a predictor of hospital mortality in cirrhotic patients
(Turk J Gastroenterol 2016; 27: 173-179)
DOI: 10.5152/tjg.2016.15467
Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus
(Turk J Gastroenterol 2015; 26: 511-516)
DOI: 10.5152/tjg.2015.15806
Autonomic neuropathy and gallbladder motility in patients with liver cirrhosis
(Turk J Gastroenterol 2015; 26: 254-258)
DOI: 10.5152/tjg.2015.4469
Is there any potential or additive effect of anemia on hepatorenal syndrome?
(Turk J Gastroenterol 2016; 27: 273-278)
DOI: 10.5152/tjg.2016.16029
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 279-283)
DOI: 10.5152/tjg.2016.16085
Incidence, causes, and outcomes of renal failure among cirrhotic patients
(Turk J Gastroenterol 2015; 26: 517-521)
DOI: 10.5152/tjg.2015.15169
Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study
(Turk J Gastroenterol 2016; 27: 180-186)
DOI: 10.5152/tjg.2016.15502
Clinical features in liver cirrhosis patients who have experienced ischemic stroke
(Turk J Gastroenterol 2014; 25: 696-701)
DOI: 10.5152/tjg.2014.5959
Effects of mannose-binding lectin and mannose-binding lectin polymorphisms on treatment response in patients with chronic hepatitis C
(Turk J Gastroenterol 2014; 25: 702-706)
DOI: 10.5152/tjg.2014.6583
Outcomes and predictors of in-hospital mortality among cirrhotic patients with non-variceal upper gastrointestinal bleeding in upper Egypt
(Turk J Gastroenterol 2014; 25: 707-713)
DOI: 10.5152/tjg.2014.6710
Quick Look to Guidelines
Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines
(Turk J Gastroenterol 2017; 28: 518-521)
DOI: 10.5152/tjg.2017.171017
Liver - Original Article
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey
(Turk J Gastroenterol 2019; 30: 331-335)
DOI: 10.5152/tjg.2018.18269
Adverse factors responsible for below-normal platelet count after laparoscopic splenectomy and azygoportal disconnection
(Turk J Gastroenterol 2019; 30: 254-259)
DOI: 10.5152/tjg.2018.18207
Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey
(Turk J Gastroenterol 2019; 30: 260-265)
DOI: 10.5152/tjg.2018.17634
Model for end-stage liver disease and pneumonia: An improved scoring model for critically ill cirrhotic patients with pneumonia
(Turk J Gastroenterol 2019; 30: 532-540)
DOI: 10.5152/tjg.2019.18421
Bacteremia in cirrhotic patients with upper gastrointestinal bleeding
(Turk J Gastroenterol 2018; 29: 164-169)
DOI: 10.5152/tjg.2018.17309
Increased occurrence of brain abscesses in cirrhotic patients: A population-based 3-year follow-up study
(Turk J Gastroenterol 2017; 28: 342-346)
DOI: 10.5152/tjg.2017.6374
Platelet count to splenic diameter ratio and other noninvasive markers as predictors of esophageal varices in patients with liver cirrhosis
(Turk J Gastroenterol 2017; 28: 347-352)
DOI: 10.5152/tjg.2017.17090
Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels
(Turk J Gastroenterol 2018; 29: 299-307)
DOI: 10.5152/tjg.2018.17570
Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity
(Turk J Gastroenterol 2018; 29: 561-565)
DOI: 10.5152/tjg.2018.18032
The relationship between fibrosis and nodule structure and esophageal varices
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2019.18665
Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores
(Turk J Gastroenterol 2018; 29: 308-315)
DOI: 10.5152/tjg.2018.17631
Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2017; 28: 361-369)
DOI: 10.5152/tjg.2017.17033
Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus
(Turk J Gastroenterol 2019; 30: 155-162)
DOI: 10.5152/tjg.2018.18237
Laparoscopic splenectomy and azygoportal disconnection combining with pre- and postoperative endoscopic intervention - A sandwich-style sequential therapy for portal hypertensive bleeding: A retrospective cohort study
(Turk J Gastroenterol 2018; 29: 669-675)
DOI: 10.5152/tjg.2018.18106
Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
(Turk J Gastroenterol 2017; 28: 283-288)
DOI: 10.5152/tjg.2017.16640
Prospective randomized single-blind study of post-operative bleeding after minor oral surgery in patients with cirrhosis
(Turk J Gastroenterol 2019; 30: 171-176)
DOI: 10.5152/tjg.2018.18078
Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis
(Turk J Gastroenterol 2019; 30: 66-74)
DOI: 10.5152/tjg.2018.18148
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globulin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients
(Turk J Gastroenterol 2018; 29: 61-66)
DOI: 10.5152/tjg.2018.17595
Safety and effectiveness of midazolam for cirrhotic patients undergoing endoscopic variceal ligation
(Turk J Gastroenterol 2018; 29: 448-455)
DOI: 10.5152/tjg.2018.17589
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol 2018; 29: 464-472)
DOI: 10.5152/tjg.2018.16597
Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.18148
Laparoscopic splenectomy and azygoportal disconnection combining with pre- and postoperative endoscopic intervention - A sandwich-style sequential therapy for portal hypertensive bleeding: A retrospective cohort study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.18106
Safety and effectiveness of midazolam for cirrhotic patients undergoing endoscopic variceal ligation
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17589
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.16597
Basic & Translational - Original Article
Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells
(Turk J Gastroenterol 2017; 28: 476-484)
DOI: 10.5152/tjg.2017.16742
Oral Presentation
Assessment of sleep pattern and quality before and after liver transplantation using different methods
(Turk J Gastroenterol 2019; 30: 8-8)
DOI: 10.5152/tjg.2019.06
Poster
Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience
(Turk J Gastroenterol 2019; 30: 10-15)
DOI: 10.5152/tjg.2019.07
Nonsirotic chronic hepatitis B presenting with hepatocellular carcinoma: a case report
(Turk J Gastroenterol 2019; 30: 16-17)
DOI: 10.5152/tjg.2019.08
Retrospective Investigation of De novo hepatitis B infection in recipients after liver transplantation by anti-HBc positive donors
(Turk J Gastroenterol 2019; 30: 20-20)
DOI: 10.5152/tjg.2019.10
A case of acute toxic hepatitis associated with Prangos ferulacea
(Turk J Gastroenterol 2019; 30: 23-23)
DOI: 10.5152/tjg.2019.12
Evaluation of rheumatologists’ awareness of hepatitis B reactivation before immunosuppressive treatment
(Turk J Gastroenterol 2019; 30: 25-25)
DOI: 10.5152/tjg.2019.14
From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis
(Turk J Gastroenterol 2019; 30: 26-28)
DOI: 10.5152/tjg.2019.15
Letrozole-induced hepatitis in 42-year-old woman with invasive ductal breast cancer
(Turk J Gastroenterol 2019; 30: 30-30)
DOI: 10.5152/tjg.2019.17
Unusal case of imunlogical liver dissease coexisting with chronic calculous cholecystitis and anatomical variation of billiary duct
(Turk J Gastroenterol 2019; 30: 33-33)
DOI: 10.5152/tjg.2019.19
Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience
(Turk J Gastroenterol 2019; 30: 34-34)
DOI: 10.5152/tjg.2019.20
Diastolic dysfunction in patients with cirrhosis and the relationship between the clinical and laboratory findings and diastolic dysfunction
(Turk J Gastroenterol 2019; 30: 35-35)
DOI: 10.5152/tjg.2019.21
Efficacy of entecavir treatment for up to 5 years in patients with HBV-related compensated cirrhosis in Turkey; real life data
(Turk J Gastroenterol 2019; 30: 36-36)
DOI: 10.5152/tjg.2019.22
A rare case of hepatitis: Giant cell hepatitis
(Turk J Gastroenterol 2019; 30: 37-37)
DOI: 10.5152/tjg.2019.23
Hepatitis b reactivation rate in patients using anti tnf theraphy: Evaluation of patients not received anti viral prophylaxis
(Turk J Gastroenterol 2019; 30: 38-38)
DOI: 10.5152/tjg.2019.24
A real-life evaluation of the effect of direct-acting antivirals in hemodialysis patients with chronic hepatitis C
(Turk J Gastroenterol 2019; 30: 39-40)
DOI: 10.5152/tjg.2019.25
Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2019; 30: 43-45)
DOI: 10.5152/tjg.2019.28
Toxic hepatitis and hyponatremia: Case report
(Turk J Gastroenterol 2019; 30: 51-52)
DOI: 10.5152/tjg.2019.33
Evaluation of 24-year followig results of patients with inactive hepatitis B
(Turk J Gastroenterol 2019; 30: 55-55)
DOI: 10.5152/tjg.2019.35
Case Report: Drug-induced liver injury mimicking hypereosinophilic syndrome
(Turk J Gastroenterol 2019; 30: 63-63)
DOI: 10.5152/tjg.2019.40
Clinical characteristics of hepatocellular carcinoma: Results from central Anatolian region of Turkey
(Turk J Gastroenterol 2019; 30: 65-65)
DOI: 10.5152/tjg.2019.42
Etiology of cirrhosis changing trends over the years: A single-center turkish experience
(Turk J Gastroenterol 2019; 30: 66-66)
DOI: 10.5152/tjg.2019.43
Liver biopsy may not be the optimal option for assessing treatment efficacy in chronic hepatitis delta (CHD) infection
(Turk J Gastroenterol 2019; 30: 67-67)
DOI: 10.5152/tjg.2019.44
Serum prolidase could be a marker for fibrosis/cirrhosis?
(Turk J Gastroenterol 2019; 30: 68-68)
DOI: 10.5152/tjg.2019.45
Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels
(Turk J Gastroenterol 2019; 30: 69-69)
DOI: 10.5152/tjg.2019.46
A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon
(Turk J Gastroenterol 2019; 30: 70-72)
DOI: 10.5152/tjg.2019.47
Prospective and Randomized Comparison of Tenofovir and Entecavir in Hepatitis B Reactivation Prophylaxis in Patients Receiving Immunosuppressive Therapy
(Turk J Gastroenterol 2019; 30: 73-73)
DOI: 10.5152/tjg.2019.48
Clinical and laboratory features of children with chronic hepatitis B infection: A single center results
(Turk J Gastroenterol 2019; 30: 74-74)
DOI: 10.5152/tjg.2019.49
Acute liver ınjury in a patient with secondary syphilis and acute viral hepatitis B coinfection
(Turk J Gastroenterol 2019; 30: 75-75)
DOI: 10.5152/tjg.2019.50
Effect of sofosbuvir on QT interval and other electrocardiography (ECG) findings in patients with HCV related decompase cirrhosis
(Turk J Gastroenterol 2019; 30: 76-76)
DOI: 10.5152/tjg.2019.51
Investigation of the factors affecting the response of treatment ın patients treated with oral direct acting antiviral agents
(Turk J Gastroenterol 2019; 30: 79-80)
DOI: 10.5152/tjg.2019.53
Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients
(Turk J Gastroenterol 2019; 30: 81-82)
DOI: 10.5152/tjg.2019.54
Awareness of hepatitis C
(Turk J Gastroenterol 2019; 30: 85-85)
DOI: 10.5152/tjg.2019.56
Diagnosis ways of chronic HBV cases
(Turk J Gastroenterol 2019; 30: 86-86)
DOI: 10.5152/tjg.2019.57
Thyroid manifestations in autoimmune liver diseases: a single center experience
(Turk J Gastroenterol 2019; 30: 89-90)
DOI: 10.5152/tjg.2019.59
Primary immune deficiency screening in patients with biopsy proven autoimmune liver diseases
(Turk J Gastroenterol 2019; 30: 91-91)
DOI: 10.5152/tjg.2019.60
Comparison of antivirals in prophylaxis of HBV reactivation in patients receiving immunsuppressive therapy
(Turk J Gastroenterol 2019; 30: 92-92)
DOI: 10.5152/tjg.2019.61
Poster Presentation
Psychometric test compliance of patients with cirrhosis in the diagnosis of minimal hepatic encephalopathy
(Turk J Gastroenterol 2019; 30: 95-96)
DOI: 10.5152/tjg.2019.63
Evaluation of diagnostic performance simple non-invasıve fibrosis markers in patients with chronic hepatitis B
(Turk J Gastroenterol 2019; 30: 100-100)
DOI: 10.5152/tjg.2019.65
The evaluation of liver biopsy specimens of chronic hepatitis B patients using early tissue markers for Hepatocellular Carcinoma: Before and after the development of Hepatocellular Carcinoma
(Turk J Gastroenterol 2019; 30: 102-102)
DOI: 10.5152/tjg.2019.67
Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey
(Turk J Gastroenterol 2019; 30: 103-105)
DOI: 10.5152/tjg.2019.68
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 30.05.2019